Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.

Participants needed: 55
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Axonics, Inc.Updated: Aug 12, 2026Locations: 2
Eligibility criteria

18 years or older [+2]

Any significant medical condition that is likely to interfere with study procedu... [+4]

Read more
Status: Recruiting

Aquarius Pilot Study to Evaluate the New Axonics Trial System

Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).

Participants needed: 75
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Axonics, Inc.Updated: Aug 12, 2026Locations: 3
Eligibility criteria

18 years or older [+2]

Any participant that the study Investigator deems to be a poor candidate for any... [+3]

Read more
Status: Recruiting

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.

Participants needed: 55
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Axonics, Inc.Updated: Aug 12, 2026Locations: 6
Eligibility criteria

18 years or older [+2]

Any significant medical condition that is likely to interfere with procedures, d... [+5]

Read more
Status: Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Participants needed: 150
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: Axonics, Inc.Updated: Aug 12, 2026Locations: 22
Eligibility criteria

Participants aged ≥ 18 years at the time of enrollment [+3]

Any patient that is not a suitable candidate per investigator discretion [+9]

Read more